|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-3-5
|
|
pubmed:abstractText |
Randomised control trial of osteoporosis screening in 4,800 women aged 45-54 years was carried out. Screened group observed an increase of 7.9% in hormone replacement therapy (HRT) use (p < 0.001), 15% in other osteoporosis treatments (p < 0.001) and a 25.9% reduction in fracture risk compared with control. Screening for osteoporosis significantly increases treatment use and reduces fracture incidence.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1433-2965
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
561-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19565176-Bone Density,
pubmed-meshheading:19565176-Bone Density Conservation Agents,
pubmed-meshheading:19565176-Chi-Square Distribution,
pubmed-meshheading:19565176-Estrogen Replacement Therapy,
pubmed-meshheading:19565176-Female,
pubmed-meshheading:19565176-Humans,
pubmed-meshheading:19565176-Mass Screening,
pubmed-meshheading:19565176-Middle Aged,
pubmed-meshheading:19565176-Osteoporosis, Postmenopausal,
pubmed-meshheading:19565176-Osteoporotic Fractures,
pubmed-meshheading:19565176-Proportional Hazards Models,
pubmed-meshheading:19565176-Scotland
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk.
|
|
pubmed:affiliation |
Bone and Musculoskeletal Research Programme, University of Aberdeen, Foresterhill, Aberdeen, UK. r.j.barr@abdn.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
